UK banks on COVID-19 antivirals for winter

By Clara-Laeila Laudette
Updated December 16 2021 - 6:56pm, first published 6:49pm
UK tests are trialling Merck's molnupiravir pill in COVID-19 patients at risk of serious illness.

The United Kingdom expects to have antiviral COVID-19 pills produced by Merck and Pfizer available over the northern hemisphere winter, its Antiviral Taskforce Chair says as Omicron continues its lightning advance through the country.

Advertisement

Ad

Advertisement

Ad